01054nas a2200397   4500000000100000008004100001260001700042653001500059653001000074653001100084653001000095653001600105653001200121653002000133653003100153653002100184653001100205653001100216653001300227653001200240653000900252653003200261653001600293653002500309653002700334653001500361100001800376700001500394700001400409700001800423245014200441856004100583300001100624490000700635022001400642       1974                            d  c1974 Jul-Sep10aAdolescent10aAdult10aBiopsy10aChild10aClofazimine10aDapsone10aDrug Evaluation10aDrug Resistance, Microbial10aErythema Nodosum10aFemale10aHumans10aLepromin10aleprosy10aMale10aMicrobial Sensitivity Tests10aMiddle Aged10aMycobacterium leprae10aPigmentation Disorders10aRecurrence1 aRodriguez J N1 aAbalos R M1 aREICH C V1 aTolentino J G00aEffects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.  uhttp://ila.ilsl.br/pdfs/v42n3a04.pdf  a276-880 v42  a0148-916X